2ZNP

human pprr delta ligand binding domain in complex with a synthetic agonist tipp204

• Total interactions analyzed: 1
• Total true interactions: 1
• Strongest Interaction:
  • Chains: A-B
  • Int. Res.: 79
  • Norm. En. per Res.: -1.8904
• Hub Node: A(1)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
A-B	-3.0279	16.0494	-162.361	-149.3395	79	9	8	7226	0	18	10

Interface residues

• A-B: ALA300A, ALA300B, ARG294A, ARG294B, ARG405A, ARG405B, ASN312A, ASN312B, ASN402A, ASN402B, ASP313A, ASP313B, GLN314A, GLN314B, GLN470A, GLN470B, GLU291A, GLU291B, GLU295A, GLU295B, GLU298A, GLU298B, GLU471A, GLU471B, GLY399A, GLY399B, HIS466A, HIS466B, ILE472A, ILE472B, LEU296A, LEU296B, LEU309A, LEU309B, LEU311A, LEU311B, LEU317A, LEU317B, LEU318A, LEU318B, LEU400A, LEU400B, LEU468A, LEU468B, LEU469A, LEU469B, LYS301A, LYS301B, LYS319A, LYS319B, LYS474B, MET401A, MET401B, PHE306A, PHE306B, PHE310A, PHE310B, PRO467A, PRO467B, SER307A, SER307B, SER308A, SER308B, THR289A, THR289B, THR292A, THR292B, THR297A, THR297B, THR316A, THR316B, VAL290A, VAL290B, VAL293A, VAL293B, VAL315A, VAL315B, VAL322B, VAL403A